StocksFundsScreenerSectorsWatchlists
USNA

USNA - USANA Health Sciences Inc Stock Price, Fair Value and News

43.14USD-0.32 (-0.74%)Market Closed

Market Summary

USNA
USD43.14-0.32
Market Closed
-0.74%

USNA Alerts

  • 2 major insider sales recently.

USNA Stock Price

View Fullscreen

USNA RSI Chart

USNA Valuation

Market Cap

830.0M

Price/Earnings (Trailing)

13.01

Price/Sales (Trailing)

0.9

EV/EBITDA

4.33

Price/Free Cashflow

14.78

USNA Price/Sales (Trailing)

USNA Profitability

EBT Margin

11.12%

Return on Equity

12.83%

Return on Assets

10.08%

Free Cashflow Yield

6.76%

USNA Fundamentals

USNA Revenue

Revenue (TTM)

921.0M

Rev. Growth (Yr)

-3.02%

Rev. Growth (Qtr)

3.62%

USNA Earnings

Earnings (TTM)

63.8M

Earnings Growth (Yr)

31.04%

Earnings Growth (Qtr)

47.76%

Breaking Down USNA Revenue

Last 7 days

-8.7%

Last 30 days

-13.9%

Last 90 days

-9.8%

Trailing 12 Months

-32.7%

How does USNA drawdown profile look like?

USNA Financial Health

Current Ratio

3.52

USNA Investor Care

Buy Backs (1Y)

0.28%

Diluted EPS (TTM)

3.3

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023974.1M947.8M927.9M921.0M
20221.2B1.1B1.0B998.6M
20211.2B1.3B1.2B1.2B
20201.1B1.1B1.1B1.1B
20191.2B1.1B1.1B1.1B
20181.1B1.1B1.2B1.2B
20171.0B1.0B1.0B1.0B
2016939.6M964.8M985.8M1.0B
2015827.4M872.4M913.8M918.5M
2014731.5M730.6M748.9M790.5M
2013663.7M691.9M700.4M718.2M
2012592.5M604.5M626.1M648.7M
2011542.1M565.0M573.5M581.9M
20100463.8M490.7M517.6M
2009000436.9M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of USANA Health Sciences Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 11, 2024
guest kevin
sold
-539,539
49.00
-11,011
exec. chairman of the board
Mar 08, 2024
noot walter
sold
-257,022
49.05
-5,240
chief operating officer
Mar 06, 2024
neidig brent
sold
-179,066
46.999
-3,810
co. & man. dir. of china
Mar 05, 2024
sinnott robert a
sold
-183,659
46.555
-3,945
chief scientific officer
Mar 04, 2024
fuller gilbert a
sold
-24,095
49.0748
-491
-
Mar 04, 2024
fleming john turman
sold
-14,696
48.9882
-300
-
Mar 01, 2024
macuga daniel a.
sold
-72,120
48.08
-1,500
chief communications officer
Feb 29, 2024
foukas joshua
sold
-232,234
47.913
-4,847
chief legal officer
Feb 29, 2024
mulham david mulham
sold
-205,872
47.755
-4,311
chief sales officer
Feb 29, 2024
pelosi peggie
sold
-23,350
48.146
-485
-

1–10 of 50

Which funds bought or sold USNA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 15, 2024
EXCHANGE TRADED CONCEPTS, LLC
reduced
-57.84
-548,177
338,045
0.01%
Apr 15, 2024
DGS Capital Management, LLC
added
61.83
111,617
352,013
0.10%
Apr 12, 2024
West Coast Financial LLC
reduced
-1.63
-266,504
2,157,720
0.26%
Apr 12, 2024
AdvisorNet Financial, Inc
added
145
720
1,310
-%
Apr 09, 2024
MASSMUTUAL TRUST CO FSB/ADV
added
2.94
-374
5,093
-%
Apr 05, 2024
FIRST HAWAIIAN BANK
added
22.28
42,408
440,817
0.01%
Apr 05, 2024
CWM, LLC
added
21.78
7,000
75,000
-%
Apr 05, 2024
GAMMA Investing LLC
added
866
5,064
5,626
-%
Apr 03, 2024
Versant Capital Management, Inc
unchanged
-
-107
1,019
-%
Apr 03, 2024
WealthCollab, LLC
new
-
25,139
25,139
0.02%

1–10 of 49

Are Funds Buying or Selling USNA?

Are funds buying USNA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own USNA
No. of Funds

Unveiling USANA Health Sciences Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
renaissance technologies llc
6.27%
1,198,697
SC 13G/A
Feb 13, 2024
vanguard group inc
8.27%
1,582,742
SC 13G/A
Jan 24, 2024
blackrock inc.
9.6%
1,836,679
SC 13G/A
Feb 13, 2023
renaissance technologies llc
6.38%
1,224,997
SC 13G/A
Feb 09, 2023
vanguard group inc
7.99%
1,534,910
SC 13G/A
Jan 06, 2023
blackrock inc.
10.2%
1,963,866
SC 13G/A
Feb 11, 2022
renaissance technologies llc
7.48%
1,456,097
SC 13G/A
Feb 10, 2022
vanguard group inc
7.70%
1,498,731
SC 13G/A
Feb 01, 2022
blackrock inc.
9.3%
1,802,996
SC 13G/A
Nov 22, 2021
wentz myron w
41.0%
7,985,743
SC 13D/A

Recent SEC filings of USANA Health Sciences Inc

View All Filings
Date Filed Form Type Document
Mar 27, 2024
ARS
ARS
Mar 27, 2024
DEFA14A
DEFA14A
Mar 22, 2024
DEF 14A
DEF 14A
Mar 11, 2024
144
Notice of Insider Sale Intent
Mar 11, 2024
144
Notice of Insider Sale Intent
Mar 11, 2024
4
Insider Trading
Mar 11, 2024
4
Insider Trading
Mar 07, 2024
4
Insider Trading
Mar 06, 2024
144
Notice of Insider Sale Intent
Mar 05, 2024
144
Notice of Insider Sale Intent

Peers (Alternatives to USANA Health Sciences Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
30.7B
93.9B
1.64% -26.67%
8.82
0.33
-7.50% -19.75%
15.1B
61.3B
8.82% 8.61%
7.7
0.25
-8.91% 30.43%
14.3B
12.1B
6.88% -19.51%
15.07
1.18
-0.78% 18.26%
12.8B
9.3B
0.70% -22.10%
16.74
1.38
1.02% -5.78%
11.6B
79.2B
-2.84% -2.27%
8.58
0.15
3.12% -18.15%
MID-CAP
7.2B
1.7B
-8.03% 59.87%
43.74
4.17
21.49% 39.64%
5.1B
766.9M
-3.56% 62.12%
-151.77
6.65
28.82% 43.50%
4.9B
5.1B
2.11% -14.53%
39.55
0.96
5.93% -45.96%
3.0B
2.4B
4.21% 10.47%
10.94
1.27
-22.17% -63.60%
2.6B
3.3B
-6.87% 24.61%
19.6
0.79
0.37% -0.15%
SMALL-CAP
1.9B
14.8B
7.32% 35.98%
19.15
0.13
-14.86% -22.80%
837.3M
2.1B
-0.93% -27.27%
-12.65
0.41
-4.65% -482.22%
422.3M
343.4M
-23.18% -55.70%
-1.25
1.23
-18.04% 7.65%
205.4M
106.3M
-4.53% 8.41%
4.28
1.93
34.67% 5930.90%
6.7M
2.5M
-19.44% 210.71%
-0.24
2.71
-21.18% -24.37%

USANA Health Sciences Inc News

Latest updates
Defense World14 Apr 202410:33 am
American Banking News10 Mar 202408:00 am

USANA Health Sciences Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue3.6%221213238248228233264273267274337308311299259267271261256273299
Gross Profit4.6%179171195200182187215221215224280250252242211221224213210227250
Operating Expenses0.9%155153170173159164186188183183226206199197172182179177178192201
  S&GA Expenses-7.3%59.0063.0068.0067.0061.0066.0066.0069.0069.0067.0072.0072.0069.0066.0061.0065.0065.0066.0067.0070.0068.00
EBITDA Margin3.9%0.13*0.12*0.12*0.12*0.12*0.13*0.14*0.15*0.15*0.17*0.17*0.17*---------
Interest Expenses237.2%0.000.000.000.000.000.000.000.000.000.000.000.00-1.111.000.000.000.000.000.000.000.00
Income Taxes7.2%10.009.0010.0010.0010.008.0010.0011.0011.0013.0016.0014.0015.0014.0012.0013.0015.0012.0011.0012.0017.00
Earnings Before Taxes29.6%27.0021.0027.0029.0023.0023.0029.0033.0032.0040.0054.0044.0055.0044.0040.0039.0046.0036.0033.0036.0049.00
EBT Margin4.6%0.11*0.11*0.11*0.11*0.11*0.11*0.12*0.14*0.14*0.16*0.16*0.16*---------
Net Income47.8%17.0011.0017.0018.0013.0015.0019.0022.0020.0027.0038.0031.0040.0031.0028.0027.0031.0024.0021.0024.0032.00
Net Income Margin7.4%0.07*0.06*0.07*0.07*0.07*0.07*0.08*0.09*0.10*0.11*0.11*0.11*---------
Free Cashflow-10.0%19.0021.006.0011.0037.0026.0013.0018.0022.0031.0038.0018.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets5.3%633601603606597556558573578579591585641578512474517463532552554
  Current Assets7.0%418390388396384341342364365368382373425386325287329283349370392
    Cash Equivalents7.6%330307300295288247230238240249265257312278227194235183231225214
  Inventory2.3%61.0060.0062.0064.0067.0067.0084.0098.0098.0096.0090.0088.0090.0078.0069.0061.0069.0076.0088.0086.0082.00
  Net PPE4.9%10095.0096.0097.0098.0095.0098.0010110210198.0099.0010099.0098.0097.0095.0092.0093.0092.0092.00
  Goodwill1.8%17.0017.0017.0017.0017.0017.001.0018.0018.0018.0017.0017.0017.0017.0017.0016.0017.0016.0017.0017.0017.00
  Current Liabilities5.6%119113114130144126134158161158153151168161140125136130129130149
Shareholder's Equity5.7%497470469455434411404390395399419403442389349318352314384391391
  Retained Earnings3.9%445428427410392379364345345350366353383343313285306275328329330
  Additional Paid-In Capital5.6%66.0062.0060.0056.0056.0052.0049.0046.0050.0051.0054.0054.0062.0059.0056.0052.0059.0057.0069.0069.0072.00
Shares Outstanding0.0%19.0019.0019.0019.0019.0019.0019.0019.0020.0020.0021.0021.00---------
Float---699---1,426---2,052---817---1,040--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations17.0%26,02322,2349,55112,83340,46329,12514,61319,70124,92237,48839,15819,65947,91549,06232,63830,78655,74050,31415,1585,52140,426
  Share Based Compensation-0.7%3,6433,6703,6743,6083,5163,0763,5563,1833,2593,4543,8453,7403,8753,5283,5973,3942,8574,0834,7693,8323,929
Cashflow From Investing-403.6%-7,322-1,454179-3,378-3,282-3,579-3,723-1,786-3,153-6,452-1,494-3,088-21,433-2,732-1,526-8,270-5,105-1,18521,27532,50915,611
Cashflow From Financing105.7%658-11,641-55.00-3,199-150-44.00-10,301-19,593-32,445-46,831-31,661-70,475-472-43.00-75.00-58,852-305-92,476-27,858-31,413-80,218
  Buy Backs-100.0%-11,657-----25,38231,34349,75129,70167,610---57,029-92,37727,62330,00079,785

USNA Income Statement

2023-12-30
Consolidated Statements of Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 30, 2023
Dec. 31, 2022
Jan. 01, 2022
Income Statement [Abstract]   
Net sales$ 921,010$ 998,601$ 1,186,464
Cost of sales176,693193,890217,898
Gross profit744,317804,711968,566
Operating expenses:   
Associate incentives394,257434,793519,267
Selling, general and administrative256,989262,304279,107
Total operating expenses651,246697,097798,374
Earnings from operations93,071107,614170,192
Other income (expense):   
Interest income9,6373,7892,515
Interest expense(262)(192)(57)
Other, net7(2,590)(2,008)
Other income (expense), net9,3821,007450
Earnings before income taxes102,453108,621170,642
Income taxes38,66539,27154,137
Net earnings$ 63,788$ 69,350$ 116,505
Earnings per common share   
Earnings per share, basic (in dollars per share)$ 3.31$ 3.60$ 5.78
Earnings per share, diluted (in dollars per share)$ 3.30$ 3.59$ 5.73
Weighted average common shares outstanding   
Basic (in shares)19,25019,25420,146
Diluted (in shares)19,34519,31020,343
Comprehensive income:   
Net earnings$ 63,788$ 69,350$ 116,505
Other comprehensive income (loss), net of tax:   
Foreign currency translation adjustment(1,298)(15,126)2,203
Tax benefit (expense) related to foreign currency translation adjustment3901,8811,880
Other comprehensive income (loss), net of tax(908)(13,245)4,083
Comprehensive income$ 62,880$ 56,105$ 120,588

USNA Balance Sheet

2023-12-30
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 30, 2023
Dec. 31, 2022
Current assets  
Cash and cash equivalents$ 330,420$ 288,420
Inventories61,45467,089
Prepaid expenses and other current assets25,87228,873
Total current assets417,746384,382
Property and equipment, net99,81497,773
Goodwill17,10217,368
Intangible assets, net29,91932,432
Deferred tax assets13,2849,799
Other assets54,89254,795
Total assets632,757596,549
Current liabilities  
Accounts payable10,07011,049
Line of credit - short term7860
Other current liabilities107,989132,784
Total current liabilities118,845143,833
Deferred tax liabilities4,5524,071
Other long-term liabilities12,15814,173
Stockholders' equity  
Common stock, $0.001 par value; Authorized -- 50,000 shares, issued and outstanding 19,130 as of December 30, 2023 and 19,206 as of December 31, 20221919
Additional paid-in capital65,66155,604
Retained earnings445,217391,636
Accumulated other comprehensive income (loss)(13,695)(12,787)
Total stockholders' equity497,202434,472
Total liabilities and equity$ 632,757$ 596,549
USNA
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
 CEO
 WEBSITEusana.com
 INDUSTRYPackaged Foods
 EMPLOYEES1900

USANA Health Sciences Inc Frequently Asked Questions


What is the ticker symbol for USANA Health Sciences Inc? What does USNA stand for in stocks?

USNA is the stock ticker symbol of USANA Health Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of USANA Health Sciences Inc (USNA)?

As of Tue Apr 16 2024, market cap of USANA Health Sciences Inc is 830.04 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of USNA stock?

You can check USNA's fair value in chart for subscribers.

What is the fair value of USNA stock?

You can check USNA's fair value in chart for subscribers. The fair value of USANA Health Sciences Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of USANA Health Sciences Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for USNA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is USANA Health Sciences Inc a good stock to buy?

The fair value guage provides a quick view whether USNA is over valued or under valued. Whether USANA Health Sciences Inc is cheap or expensive depends on the assumptions which impact USANA Health Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for USNA.

What is USANA Health Sciences Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 16 2024, USNA's PE ratio (Price to Earnings) is 13.01 and Price to Sales (PS) ratio is 0.9. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. USNA PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on USANA Health Sciences Inc's stock?

In the past 10 years, USANA Health Sciences Inc has provided 0.084 (multiply by 100 for percentage) rate of return.